Business from Research Innovation at VTT

Size: px

Start display at page:

Download "Business from Research Innovation at VTT"

Gervais Paul
8 years ago
Views:

1 Business from Research Innovation at VTT Vesi-ohjelman vuosiseminaari, Timo Pulli, Business Development Manager VTT Technical Research Centre of Finland

2011 Timo Pulli, Business Development Manager

2 2 Contents Short introduction of VTT VTT s innovation process Case examples Summary

3 3 VTT Technical Research Centre of Finland VTT IS a globally networked multitechnological applied research organisation VTT HAS extensive cross-disciplinary technological and business expertise unique research infrastructure comprehensive global partnership networks in business, industrial and research communities VTT CREATES new technology and science-based innovations in co-operation with domestic and foreign partners VTT Group Turnover 292 M (2010) Personnel 3,167 ( ) Established 1942 VTT has been granted ISO9001:2008 certificate. Focus areas of research Applied materials Bio- and chemical processes Energy Information and communication technologies Industrial systems management Microtechnologies and electronics Services and the built environment Business research

with domestic and foreign partners VTT Group Turnover 292 M (2010) Personnel 3,167 (1.1.2011) Established 1942 VTT has been granted ISO9001:2008 certificate.

4 4 VTT s innovation process

5 5 Ideas Inventions Innovations Expenses Value creation Value capture

6 6 RESEARCH VS. INNOVATION? Research = Transforming money into knowledge Innovation = Transforming knowledge into money

7 7 New Business Development Process at VTT Role is to focus on tasks that Bridge the gap between research and commercial success Involvement Strategic Research Proof-ofconcepts Idea screening Market Evaluation & Insights IPR to Protect Value Proposition Business Development Planning for Commercialization Business Model Development Business Solutions, Ventures & Expert Services Research Sales & Commercialization

Evaluation & Insights IPR to Protect Value Proposition Business Development Planning for

8 8 Role and motivation of inventor/scientists Invention Evaluation and protection Marketing and sales of IPR Spin offs Role Development of the idea to a notification of invention Technology expert Technology expert Entrepreneur Technology expert for Ventures Motivation Recognition as inventor Invention rewards, 400 Refining the idea Patent publications in CV Patent rewards, 300 / 600 Exploitation of IPR 20 (-30) % from net income Exploitation of the idea Entrepreneurship 20 (-30) % from net income

Ventures Motivation Recognition as inventor Invention rewards, 400 Refining the idea Patent publications in CV Patent

9 Case Exambles 21/11/2011 9

10 10 Examples of portfolio companies Bio Provides a high-content gene expression analysis platform IT Removable media data protection Bio Personalized medicine based on gene expression analysis database IT Network risk management Bio Generating biomarkers and targets for commercialization through analytical chemistry ICTE Manufactures touch modules based on FTIR technology ICTE Document and brand authentication and security ICTE Commercializes a physical activity meter and service concept Healthcare Treatment for head and neck cancer

fi Bio Generating biomarkers and targets for commercialization through analytical chemistry www.zorabio.com ICTE Manufactures touch modules based on FTIR technology www.

11 11 TactoTek Oy Touch screen technology is winning ground in multiple domains Touch panel market is estimated to be $8 billion and grows rapidly VTT Ventures recently established spinoff TactoTek utilizes FTIR technique combined with printed electronics manufacturing methods to develop and manufacture touch panels for mainstream applications

established spinoff TactoTek utilizes FTIR technique combined with printed

12 12 Desemtum Oy Trends indicate that half of all Europeans will suffer from allergy by 2015 Anti-allergy drugs is expected to exceed 14,7 billion USD in 2015 in US alone. VTT Ventures Oy has established a spin-off which develops next generation allergy vaccines Pekka Mattila, Desentum Oy's Managing Director, knows how to run a biotechnology company and increase its business opportunities Pekka Mattila was one of the founding members of the Finnzymes Group and acted as its CEO until 2010, when the company was sold to the American Thermo Fisher Scientific.

VTT Ventures Oy has established a spin-off which develops next generation allergy vaccines Pekka Mattila, Desentum Oy's Managing Director,

13 13 Summary: An invention is a success when it is commercialized Innovations are made in teams! Development, proof of concept, demos Marketing Customer need Competitiveness Sales Agreements Technology and patentability: -novelty - inventiveness - industrial applicability Important, but not enough

Development, proof of concept, demos Marketing Customer need

14 14 VTT creates business from technology

VTT Technical Research Centre of Finland 2010

VTT Technical Research Centre of Finland 2010 02/04/2010 2 GDP share of R&D expenditure in Finland % 3 3.43 3.45 3.48 3.45 3.47 3.72 3.92 2.1 1990 1998 2003 2004 2005 2006 2007 2008 2009 Source: Statistics